General information about company
Scrip code	516096
NSE Symbol
MSEI Symbol
ISIN*	INE384D01022
Name of company	SANGAL PAPERS LIMITED
Type of company
Class of security	Equity
Date of start of financial year	01-04-2022
Date of end of financial year	31-03-2023
Date of board meeting when results were approved	27-05-2023
Date on which prior intimation of the meeting for considering financial results was informed to the exchange	21-05-2023
Description of presentation currency	INR
Level of rounding used in financial results	Lakhs
Reporting Quarter	Yearly
Nature of report standalone or consolidated	Standalone
Whether results are audited or unaudited	Audited
Segment Reporting	Single segment
Description of single segment	Manufacturing of paper
Start date and time of board meeting	27-05-2023 12:00
End date and time of board meeting	27-05-2023 16:00
Whether cash flow statement is applicable on company	Yes
Type of cash flow statement	Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification	Declaration of unmodified opinion

Financial Results – Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-01-2023	01-04-2022
B	Date of end of reporting period	31-03-2023	31-03-2023
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1	Income
	Revenue from operations	5976.497	22610.346
	Other income	42.827	202.028
	Total income	6019.324	22812.374
2	Expenses
(a)	Cost of materials consumed	5292.282	20320.296
(b)	Purchases of stock-in-trade	4.741	8.031
(c)	Changes in inventories of finished goods, work-in-progress and stock-in-trade	35.38	-158.638
(d)	Employee benefit expense	223.838	835.137
(e)	Finance costs	60.204	193.897
(f)	Depreciation, depletion and amortisation expense	48.585	159.012
(f)	Other Expenses
1	Printing and Stationary	3.856	6.331
2	Communication Expenses	4.485	11.681
3	Travelling & Conveyance	1.49	6.085
4	Insurance Charges	10.159	35.82
5	Legal and Professional Charges	4.296	21.542
6	Repair to Buildings	13.03	52.238
7	Rates and Taxes	17.495	34.927
8	Auditors remuneration	0.375	1.5
9	Selling and Forwarding	227.877	727.86
10	Other Expenses	-11.05	76.821
	Total other expenses	272.013	974.805
	Total expenses	5937.043	22332.54

Financial Results – Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-01-2023	01-04-2022
B	Date of end of reporting period	31-03-2023	31-03-2023
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
3	Total profit before exceptional items and tax	82.281	479.834
4	Exceptional items	0	0
5	Total profit before tax	82.281	479.834
7	Tax expense
8	Current tax	-2.49	81.374
9	Deferred tax	22.38	59.87
10	Total tax expenses	19.89	141.244
11	Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement	0	0
14	Net Profit Loss for the period from continuing operations	62.391	338.59
15	Profit (loss) from discontinued operations before tax	0	0
16	Tax expense of discontinued operations	0	0
17	Net profit (loss) from discontinued operation after tax	0	0
19	Share of profit (loss) of associates and joint ventures accounted for using equity method	0	0
21	Total profit (loss) for period	62.391	338.59

Financial Results – Ind-AS
Particulars		3 months/ 6 month ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-01-2023	01-04-2022
B	Date of end of reporting period	31-03-2023	31-03-2023
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
	Other comprehensive income [Abstract]
1	Amount of items that will not be reclassified to profit and loss
	Total Amount of items that will not be reclassified to profit and loss
2	Income tax relating to items that will not be reclassified to profit or loss	0.668	5.58
3	Amount of items that will be reclassified to profit and loss
	Total Amount of items that will be reclassified to profit and loss
4	Income tax relating to items that will be reclassified to profit or loss	-0.173	-1.45
5	Total Other comprehensive income	-0.495	-4.13

Financial Results – Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-01-2023	01-04-2022
B	Date of end of reporting period	31-03-2023	31-03-2023
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
23	Total Comprehensive Income for the period	61.896	334.46
24	Total profit or loss, attributable to
	Profit or loss, attributable to owners of parent
	Total profit or loss, attributable to non-controlling interests
25	Total Comprehensive income for the period attributable to
	Comprehensive income for the period attributable to owners of parent	0	0
	Total comprehensive income for the period attributable to owners of parent non-controlling interests	0	0
26	Details of equity share capital
	Paid-up equity share capital	130.726	130.726
	Face value of equity share capital	10	10
27	Details of debt securities
28	Reserves excluding revaluation reserve		0
29	Earnings per share
i	Earnings per equity share for continuing operations
	Basic earnings (loss) per share from continuing operations	4.77	25.91
	Diluted earnings (loss) per share from continuing operations	4.77	25.91
ii	Earnings per equity share for discontinued operations
	Basic earnings (loss) per share from discontinued operations	0	0
	Diluted earnings (loss) per share from discontinued operations	0	0
ii	Earnings per equity share
	Basic earnings (loss) per share from continuing and discontinued operations	4.77	25.91
	Diluted earnings (loss) per share from continuing and discontinued operations	4.77	25.91
30	Debt equity ratio
31	Debt service coverage ratio
32	Interest service coverage ratio
33	Disclosure of notes on financial results	Textual Information(1)

Text Block
Textual Information(1)	Other expenses are negative due to re-grouping of certain expenses as bank charges into finance charges.

Statement of Asset and Liabilities
Particulars		Current year ended (dd-mm-yyyy)
Date of start of reporting period		01-04-2022
Date of end of reporting period		31-03-2023
Whether results are audited or unaudited		Audited
Nature of report standalone or consolidated		Standalone
	Assets
1	Non-current assets
	Property, plant and equipment	3632.978
	Capital work-in-progress	0
	Investment property	0
	Goodwill	0
	Other intangible assets	0
	Intangible assets under development	0
	Biological assets other than bearer plants	0
	Investments accounted for using equity method	0
	Non-current financial assets
	Non-current investments	0
	Trade receivables, non-current	0
	Loans, non-current	14.55
	Other non-current financial assets	28.866
	Total non-current financial assets	43.416
	Deferred tax assets (net)	0
	Other non-current assets	0
	Total non-current assets	3676.394
2	Current assets
	Inventories	2223.786
	Current financial asset
	Current investments	0
	Trade receivables, current	2856.33
	Cash and cash equivalents	96.017
	Bank balance other than cash and cash equivalents	10
	Loans, current	0
	Other current financial assets	0
	Total current financial assets	2962.347
	Current tax assets (net)	25.397
	Other current assets	125.373
	Total current assets	5336.903

Statement of Asset and Liabilities
Particulars		Current year ended (dd-mm-yyyy)
Date of start of reporting period		01-04-2022
Date of end of reporting period		31-03-2023
Whether results are audited or unaudited		Audited
Nature of report standalone or consolidated		Standalone
3	Non-current assets classified as held for sale	0
4	Regulatory deferral account debit balances and related deferred tax Assets	0
	Total assets	9013.297
	Equity and liabilities
	Equity
	Equity attributable to owners of parent
	Equity share capital	130.726
	Other equity	3782.501
	Total equity attributable to owners of parent	3913.227
	Non controlling interest
	Total equity	3913.227
	Liabilities
	Non-current liabilities
	Non-current financial liabilities
	Borrowings, non-current	968.066
	Trade payables, non-current	0
	Other non-current financial liabilities	0
	Total non-current financial liabilities	968.066
	Provisions, non-current	75.849
	Deferred tax liabilities (net)	395.441
	Deferred government grants, Non-current	0
	Other non-current liabilities	0
	Total non-current liabilities	1439.356
	Current liabilities
	Current financial liabilities
	Borrowings, current	1525.225
	Trade payables, current	1821.237
	Other current financial liabilities	108.222
	Total current financial liabilities	3454.684
	Other current liabilities	163.315
	Provisions, current	42.715
	Current tax liabilities (Net)	0
	Deferred government grants, Current	0
	Total current liabilities	3660.714
3	Liabilities directly associated with assets in disposal group classified as held for sale	0
4	Regulatory deferral account credit balances and related deferred tax liability	0
	Total liabilities	5100.07
	Total equity and liabilites	9013.297
	Disclosure of notes on assets and liabilities

Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars		3 months/ 6 month ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period		01-01-2023	01-04-2022
Date of end of reporting period		31-03-2023	31-03-2023
Whether accounts are audited or unaudited		Audited	Audited
Nature of report standalone or consolidated		Standalone	Standalone
1	Segment Revenue (Income)
	(net sale/income from each segment should be disclosed)
	Total Segment Revenue
	Less: Inter segment revenue
	Revenue from operations
2	Segment Result
	Profit (+) / Loss (-) before tax and interest from each segment
	Total Profit before tax
	i. Finance cost
	ii. Other Unallocable Expenditure net off Unallocable income
	Profit before tax
3	(Segment Asset - Segment Liabilities)
	Segment Asset
	Total Segment Asset
	Un-allocable Assets
	Net Segment Asset
4	Segment Liabilities
	Segment Liabilities
	Total Segment Liabilities
	Un-allocable Liabilities
	Net Segment Liabilities
	Disclosure of notes on segments

Cash flow statement, indirect
Particulars		Year ended (dd-mm-yyyy)
A	Date of start of reporting period	01-04-2022
B	Date of end of reporting period	31-03-2023
C	Whether results are audited or unaudited	Audited
D	Nature of report standalone or consolidated	Standalone
Part I	Blue color marked fields are non-mandatory.
	Statement of cash flows
	Cash flows from used in operating activities
	Profit before tax	479.834
	Adjustments for reconcile profit (loss)
	Adjustments for finance costs	193.9
	Adjustments for decrease (increase) in inventories	-570.09
	Adjustments for decrease (increase) in trade receivables, current	-396.32
	Adjustments for decrease (increase) in trade receivables, non-current	0
	Adjustments for decrease (increase) in other current assets	-60.39
	Adjustments for decrease (increase) in other non-current assets	128.38
	Adjustments for other financial assets, non-current	0
	Adjustments for other financial assets, current	0
	Adjustments for other bank balances	-10
	Adjustments for increase (decrease) in trade payables, current	524.96
	Adjustments for increase (decrease) in trade payables, non-current	0
	Adjustments for increase (decrease) in other current liabilities	67.87
	Adjustments for increase (decrease) in other non-current liabilities	0
	Adjustments for depreciation and amortisation expense	159.01
	Adjustments for impairment loss reversal of impairment loss recognised in profit or loss	0
	Adjustments for provisions, current	6.62
	Adjustments for provisions, non-current	10.88
	Adjustments for other financial liabilities, current	8.22
	Adjustments for other financial liabilities, non-current	0
	Adjustments for unrealised foreign exchange losses gains	0
	Adjustments for dividend income	0
	Adjustments for interest income	0
	Adjustments for share-based payments	0
	Adjustments for fair value losses (gains)	0
	Adjustments for undistributed profits of associates	0
	Other adjustments for which cash effects are investing or financing cash flow	0
	Other adjustments to reconcile profit (loss)	0
	Other adjustments for non-cash items	-6.67
	Share of profit and loss from partnership firm or association of persons or limited liability partnerships	0
	Total adjustments for reconcile profit (loss)	56.37
	Net cash flows from (used in) operations	536.204
	Dividends received	0
	Interest paid	0
	Interest received	0
	Income taxes paid (refund)	81.37
	Other inflows (outflows) of cash	-5.79
	Net cash flows from (used in) operating activities	449.044
	Cash flows from used in investing activities
	Cash flows from losing control of subsidiaries or other businesses	0
	Cash flows used in obtaining control of subsidiaries or other businesses	0
	Other cash receipts from sales of equity or debt instruments of other entities	0
	Other cash payments to acquire equity or debt instruments of other entities	0
	Other cash receipts from sales of interests in joint ventures	0
	Other cash payments to acquire interests in joint ventures	0
	Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships	0
	Cash payment for investment in partnership firm or association of persons or limited liability partnerships	0
	Proceeds from sales of property, plant and equipment	86.5
	Purchase of property, plant and equipment	836.94
	Proceeds from sales of investment property	0
	Purchase of investment property	0
	Proceeds from sales of intangible assets	0
	Purchase of intangible assets	0
	Proceeds from sales of intangible assets under development	0
	Purchase of intangible assets under development	0
	Proceeds from sales of goodwill	0
	Purchase of goodwill	0
	Proceeds from biological assets other than bearer plants	0
	Purchase of biological assets other than bearer plants	0
	Proceeds from government grants	0
	Proceeds from sales of other long-term assets	0
	Purchase of other long-term assets	0
	Cash advances and loans made to other parties	0
	Cash receipts from repayment of advances and loans made to other parties	0
	Cash payments for future contracts, forward contracts, option contracts and swap contracts	0
	Cash receipts from future contracts, forward contracts, option contracts and swap contracts	0
	Dividends received	0
	Interest received	0.61
	Income taxes paid (refund)	0
	Other inflows (outflows) of cash	0
	Net cash flows from (used in) investing activities	-749.83
	Cash flows from used in financing activities
	Proceeds from changes in ownership interests in subsidiaries	0
	Payments from changes in ownership interests in subsidiaries	0
	Proceeds from issuing shares	0
	Proceeds from issuing other equity instruments	0
	Payments to acquire or redeem entity's shares	0
	Payments of other equity instruments	0
	Proceeds from exercise of stock options	0
	Proceeds from issuing debentures notes bonds etc	0
	Proceeds from borrowings	576.47
	Repayments of borrowings	0
	Payments of finance lease liabilities	0
	Payments of lease liabilities	0
	Dividends paid	0
	Interest paid	193.9
	Income taxes paid (refund)	0
	Other inflows (outflows) of cash	0
	Net cash flows from (used in) financing activities	382.57
	Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes	81.784
	Effect of exchange rate changes on cash and cash equivalents
	Effect of exchange rate changes on cash and cash equivalents	0
	Net increase (decrease) in cash and cash equivalents	81.784
	Cash and cash equivalents cash flow statement at beginning of period	14.245
	Cash and cash equivalents cash flow statement at end of period	96.029